The contribution of blood vessel dysfunction in inflammatory bowel disease (IBD) has not been investigated thus far. We want to validate the presence of blood vessel dysfunction in IBD and test the therapeutic effect of two established blood vessel-normalizing strategies in mouse models of intestinal inflammation (selective knock-out of endothelial PHD2 and neutralizing antibodies directed against placental growth factor).